2,242
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Improved anticancer activity of betulinic acid on breast cancer through a grafted copolymer-based micelles system

, , , , &
Pages 1962-1971 | Received 26 Jul 2021, Accepted 06 Sep 2021, Published online: 25 Sep 2021

References

  • Arun B, Akar U, Gutierrez-Barrera AM, et al. (2015).The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells. Int J Oncol 47:262–8.
  • Azim HA, Ibrahim AS. (2014). Breast cancer in Egypt, China and Chinese: statistics and beyond. J Thorac Dis 6:864–6.
  • Berz D, Wanebo H. (2011). Targeting the growth factors and angiogenesis pathways: small molecules in solid tumors. J Surg Oncol 103:574–86.
  • Bi YL, Mi PY, Zhao SJ, et al. (2017). Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis. Int J Mol Med39:1255–61.
  • Cai Y, Zheng Y, Gu J, et al. (2018).Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78. Cell Death Dis 9:636.
  • Carmeliet P, Jain RK. (2011). Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298–307.
  • ChenXL, NamJO, JeanC, et al. (2012). VEGF-induced vascular permeability is mediated by FAK. Dev Cell 22:146–57.
  • Chen YJ, Wu CL, Liu JF, et al. (2010). Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress. Cancer Lett 291:20–30.
  • DeSantis CE, Ma JM, Gaudet MM, et al. (2019). Breast cancer statistics, 2019.CA A Cancer J Clin 69:438–51.
  • Dian LH, Yu EJ, Chen XN, et al. (2014). Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles.Nanoscale Res Lett 9:2406.
  • Dutta D, Paul B, Mukherjee B, et al. (2019). Nanoencapsulated betulinic acid analogue distinctively improves colorectal carcinoma in vitro and in vivo. Sci Rep 9:11506.
  • Fang H, Cong L, Zhi Y, et al. (2016). T-2 toxin inhibits murine ES cells cardiac differentiation and mitochondrial biogenesis by ROS and p-38 MAPK-mediated pathway. Toxicol Lett258:259–66.
  • Fleury C, Mignotte B, Vayssiere JL. (2002). Mitochondrial reactive oxygen species in cell death signaling.Biochimie 84:131–41.
  • Guo C, Cui F, Li M, et al. (2015). Enhanced corneal permeation of coumarin-6 using nanoliposomes containing dipotassium glycyrrhizinate: in vitro mechanism and in vivo permeation evaluation. RSC Adv 5:75636–47.
  • Guo C, Hou Y, Yu X, et al. (2020). The ERK-MNK-eIF4F signaling pathway mediates TPDHT-inducedA549 cell death in vitro and in vivo. Food Chem Toxicol 137:111158.
  • Guo C, Li M, Qi X, et al. (2016). Intranasal delivery of nanomicelle curcumin promotes corneal epithelial wound healing in streptozotocin-induced diabetic mice. Sci Rep 6:29753.
  • Guo C, Zhang Y, Yang Z, et al. (2015). Nanomicelle formulation for topical delivery of cyclosporine A into the cornea: in vitro mechanism and in vivo permeation evaluation. Sci Rep 5:12968
  • Gupta S. (2001). Molecular steps of death receptor and mitochondrial pathways of apoptosis.Life Sci69:2957–64.
  • Hou J, Sun E, Sun C, et al. (2016). Improved oral bioavailability and anticancer efficacy on breast cancer of paclitaxel via NovelSoluplus(®)-Solutol(®) HS15 binary mixed micelles system. Int J Pharm512:186–93.
  • Jawad M, Yu N, Russell NH, Pallis M. (2010). DNA damage-induced leukaemic stem and progenitor cell kill with mylotarg and tipifarnib/zarnestra drug combination in acute myeloid leukemia (AML). Blood 116:1824–761.
  • Jiao L, Wang S, Zheng Y, et al. (2019). Betulinic acid suppresses breast cancer aerobic glycolysis viacaveolin-1/NF-κB/c-Myc pathway. Biochem Pharmacol161:149–62.
  • Ke ZC, Zhang ZH, Wu H, et al. (2017). Optimization and evaluation of Oridonin-loaded Soluplus®-Pluronic P105 mixed micelles for oral administration. Int J Pharm 518:193–202.
  • Li F, Li C, Zhang H, et al. (2012). VI-14, a novel flavonoid derivative, inhibits migration and invasion of human breast cancer cells. Toxicol Appl Pharmacol 261:217–26.
  • Liao L, Liu C, Xie X, Zhou J. (2020). Betulinic acid induces apoptosis and impairs migration and invasion in a mouse model of ovarian cancer. J Food Biochem 44:e13278.
  • Matulonis UA, Harter P, Gourley C, et al. (2016). Olaparib maintenance therapy in patients with platinum-sensitive, relapsed serous ovarian cancer and a BRCA mutation: overall survival adjusted for postprogression poly(adenosine diphosphate ribose) polymerase inhibitor therapy. Cancer122:1844–52.
  • McLean L, Soto U, Agama K, et al. (2008). Aminoflavone induces oxidative DNA damage and reactive oxidative species-mediated apoptosis in breast cancer cells. Int J Cancer 122:1665–74.
  • Moreira DC, Sniderman E, Mukkada S, et al. (2021). The Global COVID-19 Observatory and Resource Center for childhood cancer: a response for the pediatric oncology community by SIOP and St. Jude Global. Pediatr Blood Cancer 68:e28962.
  • Nam S, Lee JJ, Lee SY, et al. (2017). Angelica gigas Nakai extract-loaded fast-dissolving nanofiber based on poly(vinyl alcohol) and Soluplus for oral cancer therapy. Int J Pharm 526:225–34.
  • Palazon A, Tyrakis PA, Macias D, et al (2017). AnHIF-1α/VEGF-A axis in cytotoxic T cells regulates tumor progression. Cancer Cell 32:669–83 e665.
  • Pang X, Zhang L, Lai L, et al. (2011). 1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway. Carcinogenesis32:904–12.
  • Rios JL, Manez S. (2018). New pharmacological opportunities for betulinic acid.Planta Med 84:8–19.
  • Sacewicz I, Wiktorska M, Wysocki T, Niewiarowska J. (2009). Mechanisms of cancer angiogenesis.Postep Hig Med Dosw 63:159–68.
  • Schmoll HJ. (2011). Angiogenesis Inhibition In Solid Tumors. Basic Clin Pharmacol 109:7.
  • Siegel RL, Miller KD, Jemal A. (2020). Cancer statistics, 2020.CA A Cancer J Clin 70:7–30.
  • Sung H, Ferlay J, Siegel RL, et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-Cancer J Clin 71:209–249.
  • Tavora B, Batista S, Reynolds LE, et al. (2010). Endothelial FAK is required for tumour angiogenesis. EMBO Mol Med 2:516–528.
  • Wang R, Yang M, Li G, et al. (2019). Paclitaxel-betulinic acid hybrid nanosuspensions for enhanced anti-breast cancer activity. Colloids Surf B Biointerfaces174: 270–279.
  • Wang J, Yang H, Li Q, et al. (2020). Novel nanomicelles based on rebaudioside A: a potential nanoplatform for oral delivery of honokiol with enhanced oral bioavailability and antitumor activity. Int J Pharm 590:119899.
  • Wang X, Lu X, Zhu R, et al. (2017). Betulinic acid induces apoptosis in differentiated PC12 cells via ROS-mediated mitochondrial pathway. Neurochem Res 42:1130–1140.
  • Zheng Y, Liu P, Wang N, et al. (2019). Betulinic acid suppresses breast cancer metastasis by targeting GRP78-mediated glycolysis and ER stress apoptotic pathway. Oxid Med Cell Longev 2019:8781690–15.
  • Zhu CL, Gong S, Ding JS, et al. (2019). Supersaturated polymeric micelles for oral silybin delivery: the role of the Soluplus-PVPVA complex. Acta Pharm Sin B 9:107–117.